159 related articles for article (PubMed ID: 35443863)
1. CTSV (cathepsin V) promotes bladder cancer progression by increasing NF-κB activity.
Xia Y; Ge M; Xia L; Shan G; Qian H
Bioengineered; 2022 Apr; 13(4):10180-10190. PubMed ID: 35443863
[TBL] [Abstract][Full Text] [Related]
2. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
[TBL] [Abstract][Full Text] [Related]
3. Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice.
Sevenich L; Hagemann S; Stoeckle C; Tolosa E; Peters C; Reinheckel T
Biochimie; 2010 Nov; 92(11):1674-80. PubMed ID: 20347002
[TBL] [Abstract][Full Text] [Related]
4. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
5. Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells through Targeting CTSC and CTSV Expression.
Lin CL; Hung TW; Ying TH; Lin CJ; Hsieh YH; Chen CM
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331211
[TBL] [Abstract][Full Text] [Related]
6. NAT10 Promotes Malignant Progression of Lung Cancer via the NF-κB Signaling Pathway.
Liu X; Liu X; Zhuo C; Shen J; Lu K; Sha M; Ye J; Huang J; Han H; Yu H
Discov Med; 2023 Dec; 35(179):936-945. PubMed ID: 38058058
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin V Mediates the Tazarotene-induced Gene 1-induced Reduction in Invasion in Colorectal Cancer Cells.
Wang CH; Wang LK; Wu CC; Chen ML; Kuo CY; Shyu RY; Tsai FM
Cell Biochem Biophys; 2020 Dec; 78(4):483-494. PubMed ID: 32918681
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin V drives lung cancer progression by shaping the immunosuppressive environment and adhesion molecules cleavage.
Zhu L; Zeng Q; Wang J; Deng F; Jin S
Aging (Albany NY); 2023 Dec; 15(23):13961-13979. PubMed ID: 38078882
[TBL] [Abstract][Full Text] [Related]
9. ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
Li X; Shang D; Shen H; Song J; Hao G; Tian Y
Biomed Pharmacother; 2020 Jun; 126():110066. PubMed ID: 32172065
[TBL] [Abstract][Full Text] [Related]
10. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
11. Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling.
Li G; Wang M; Ren L; Li H; Liu Q; Ouyang Y; He L; Li F
Biomed Pharmacother; 2019 Sep; 117():109112. PubMed ID: 31212130
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ.
Toss M; Miligy I; Gorringe K; Mittal K; Aneja R; Ellis I; Green A; Rakha E
J Clin Pathol; 2020 Feb; 73(2):76-82. PubMed ID: 31444238
[TBL] [Abstract][Full Text] [Related]
13. NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway.
Tang F; Yu H; Wang X; Shi J; Chen Z; Wang H; Wan Z; Fu Q; Hu X; Zuhaer Y; Liu T; Yang Z; Peng J
Biochem Biophys Res Commun; 2022 Sep; 622():101-107. PubMed ID: 35843088
[TBL] [Abstract][Full Text] [Related]
14. SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer.
Mukherjee N; Cardenas E; Bedolla R; Ghosh R
Oncotarget; 2017 Feb; 8(9):15114-15125. PubMed ID: 28122346
[TBL] [Abstract][Full Text] [Related]
15. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
[TBL] [Abstract][Full Text] [Related]
16. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
Man X; Piao C; Lin X; Kong C; Cui X; Jiang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):259. PubMed ID: 31200745
[TBL] [Abstract][Full Text] [Related]
17. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
Chiang CH; Chung JG; Hsu FT
Environ Toxicol; 2019 Jun; 34(6):679-688. PubMed ID: 30801954
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-106b overexpression alleviates inflammation injury of cardiac endothelial cells by targeting BLNK via the NF-κB signaling pathway.
An Z; Yang G; Nie W; Ren J; Wang D
J Cell Biochem; 2018 Apr; 119(4):3451-3463. PubMed ID: 29144032
[TBL] [Abstract][Full Text] [Related]
19. S100A4 suppresses cancer stem cell proliferation via interaction with the IKK/NF-κB signaling pathway.
Zhu Y; Zhou Y; Zhou X; Guo Y; Huang D; Zhang J; Wang C; Cai L
BMC Cancer; 2018 Jul; 18(1):763. PubMed ID: 30045697
[TBL] [Abstract][Full Text] [Related]
20. Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.
Huang K; Gao L; Yang M; Wang J; Wang Z; Wang L; Wang G; Li H
Int J Biochem Cell Biol; 2017 Aug; 89():6-15. PubMed ID: 28522343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
